Current Month 2013
Article Features
  Annual vs. Biennial Mammography and Breast Tumor Prognostic Characteristics
Breast Cancer Becoming as Common Among African-American Women as Among White Women
Decoding the Microbial Signature of Triple Negative Breast Cancer
Decoding the Microbial Signature of Triple Negative Breast Cancer
Device Improves Health and Saves Costs for Patients with Lymphedema
Drug for Digestive Problem Can Extend Survival for Many Advanced Cancer Patients
Exercise Could Give Margin of Safety to Women Who Want to Delay Preventive Mastectomy
Family Risk of Breast Cancer Does Not Affect Psychosocial Adjustment Among Pre-Teen Girls
High-Grade DCIS Detection Rates Increase in Older Women
Later Age Recommended for First Screening Mammogram
Marker May Predict Risk of Breast Cancer Spreading to the Brain
Much Lower Doses of Common Product Ingredient Might Increase Breast Cancer Risk
No Need to Stop Antidepressants Before Plastic Surgery, Evidence Suggests
Optical Scanner Shows Potential for Real-Time 3-D Breast Cancer Screening
Predictive Model Could Help Guide Choices for Breast Cancer Therapies
Researchers Find Pathway to Cancer-Associated Muscle Weakness
Scientists Uncover Genetic Landscape of Distinct Breast Tumors
Study Combats Anxiety as Barrier to Breast Cancer Screening
Study Reveals Why Cancer Anemia Treatment Leads to Tumor Growth
Study Shows Association Between Breastfeeding and Reduced Risk of Aggressive Breast Cancer
Women Getting BRCA Testing Not Receiving Counseling by Trained Genetic Professionals

Women Getting BRCA Testing Not Receiving Counseling by Trained Genetic Professionals

Most women who underwent BRCA genetic testing did not receive genetic counseling by trained genetics professionals and the lack of clinician recommendation was the most commonly reported reason in a study of commercially insured women, according to an article published in the journal JAMA Oncology.

Women with susceptibility to hereditary breast and ovarian cancer (HBOC) face high lifetime risks of 24 percent to 86 percent for breast cancer and 16 percent to 67 percent for ovarian cancer. Professional guidelines delineate clinical criteria based on personal and family history and recommend, for women who meet the criteria, consultation with a professionally trained, board-certified genetics clinician for genetic counseling.

Rebecca Sutphen, M.D., of the University of South Florida Morsani College of Medicine, Tampa, and coauthors examined the factors associated with use of BRCA testing, assessed whether delivery of genetic counseling and testing services adheres to professional guidelines, and measured the impact on patient reported outcomes.

Read More of the Main Article

Visit the Ezine

Visit the BreastCenter

Visit the Quality Corner
Avon Breast Cancer Crusade - AVON the company for women

  This website is supported in part by an unrestricted educational grant provided by Avon